Cangrelor versus no cangrelor during percutaneous coronary intervention in hemodynamically unstable patients: a cohort study on benefits and risks
Event: ESC Congress 2024
Topic: Antiplatelet Drugs
Session: Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention
Heparin pre-treatment in patients with ST elevation myocardial infarction: a cohort study investigating the effects on coronary artery occlusion, mortality, and bleeding
Event: ESC Congress 2022
Topic: Adjunctive Pharmacotherapy
Session: Optimising PCI: imaging, pharmacology and more
